According to the new market research report "Cell
Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell
Type (Human Stem & Differentiated, Animal), Process Stages (Cell
Processing, Distribution, Handling, QC), End User, and Region - Global Forecast
to 2023", published by
MarketsandMarkets™, The global cell therapy technologies market is projected to
reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of
14.4% during the forecast period.
Don’t miss out on
business opportunities in Cell
Therapy Technologies Market.
Rising government investments for cell-based research, the
increasing number of GMP-certified production facilities, and the large number
of oncology-oriented cell-based therapy clinical trials are the key factors
driving the growth of this cell therapy technologies market.
Consumables are
expected to account for the largest cell therapy technologies market share in
2018
By product, the cell therapy technologies market is
segmented into consumables, equipment, and systems & software. The
consumables segment is expected to account for the largest share of the market
in 2018. Factors such as increasing investments by companies to develop
advanced products as well as government initiatives for enhancing cell-based
research are contributing to the growth of the cell therapy consumables market.
To
know about the assumptions considered for the study, download the pdf
brochure
Browse and in-depth
TOC on " Cell Therapy Technologies Market "
75 - Tables
30 - Figures
116 - Pages
Get Free 10%
customization:
Cell processing
segment to witness the highest growth during the forecast period
Based on process, the cell therapy technologies market is
segmented into cell processing; cell preservation, distribution, and handling;
and process monitoring and quality control. The cell processing segment is
expected to account for the largest market share in 2018 and is projected to
witness the highest CAGR during the forecasted period. The cell processing
stage makes the highest use of cell therapy instruments and media, especially during
culture media processing. This is the major factor responsible for the large
share and high growth of this segment.
Key Market Players
Key players in this cell therapy technologies market include
Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US),
Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL
Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific
(US).
No comments:
Post a Comment